HIV INFECTIONS

This study is testing whether a coaching program called WeCare can help men who have sex with men in South Africa better manage their mental health and stick to their HIV prevention or treatment medications. The program combines problem-solving therapy with practical skills for t…

This study provides continued access to HIV treatment for people who completed previous ViiV Healthcare studies and are still benefiting from the medication but don't have local access options. It will include about 183 participants who successfully finished earlier studies and c…

This early-stage study is testing whether the cancer medication dasatinib can reduce the hidden HIV that persists in the body even during effective treatment. Fourteen adults with well-controlled HIV on long-term therapy will take either dasatinib or a placebo pill for 12 weeks. …

This study is testing whether daily cookies made with Golden Rice and red betel leaf can help lower high blood sugar and improve quality of life in adults living with HIV. Researchers will compare these special cookies to regular cookies over 28 days. The goal is to find a safe, …

This study is developing and testing a counseling program for people with HIV in South Africa. The program aims to help participants manage common, interconnected struggles like depression, trauma, and food insecurity, which can make it harder to stick to HIV medication. Research…

This study is testing a counseling program designed to help men living with HIV in Uganda tell their sexual partners about their status. The program includes education, communication skills training, and personalized planning. Researchers want to see if this approach helps men di…

This study is testing whether an automated AI chatbot can encourage men to get tested for HIV. 80 men in Malaysia will be randomly assigned to either use the chatbot or receive standard educational materials. The chatbot sends personalized messages with information and motivation…

This study is testing a new program called PrEPwise, which uses community health workers to help Black women in Virginia understand and access PrEP—a daily pill that is 99% effective at preventing HIV. The program provides culturally sensitive education and decision-making suppor…

This study aims to see if offering HIV prevention medications (PrEP and PEP) and routine STI testing at retail pharmacies is a practical and effective way to protect young women in Kenya. It will involve 720 young women seeking contraception and compare different combinations of …

This study aims to prevent HIV infections and help manage opioid addiction for people transitioning from jail back to the community. Researchers will test whether long-acting injection treatments work better than daily pills at keeping people on their medications. The study invol…

This study aims to see if women are better at taking their daily medication when it comes in one combined pill versus two separate pills. The one pill would provide both HIV prevention and birth control. Researchers will measure how consistently 300 women take each option and ask…

This study aims to improve care for adolescents and young adults after a sexual assault. It will test adding same-day HIV prevention medication and substance use screening to the standard exam. Researchers will work with survivors to design the program and then pilot it with 40 p…

This study aims to test the safety and how the drug cabotegravir works in the bodies of newborns exposed to HIV. It will involve 66 healthy babies born to mothers with HIV, who will receive either oral or injectable forms of the drug. The main goal is to gather information to pot…

This study aims to see how well people in real-world clinics stick with a long-acting injectable drug called lenacapavir to prevent HIV. It will follow 3000 people across the United States for up to two years to understand how they start, use, and sometimes stop this prevention m…

This study is testing an experimental HIV vaccine in infants born to mothers with HIV, but who are not infected themselves. The main goals are to see if the vaccine is safe and if it triggers a protective immune response in the babies. This is an early-stage trial with a small gr…

This study aims to understand if two safe dietary supplements—a specific probiotic or blueberry extract—can affect markers of immune system aging in people with HIV who drink alcohol. It is a research study, not a treatment trial. Participants will try each supplement for four we…